Adjunctive, Low-dose tPA in Primary PCI for STEMI | MicrobiomeTrials← Back to trialsNCT03335839
Adjunctive, Low-dose tPA in Primary PCI for STEMI
CompletedPHASE3INTERVENTIONAL
Trial Details
Start: 2018-04-01Est. Completion: 2024-09-17
Enrollment target: 210 participants Locations- University of Calgary - Foothills Medical Centre, Calgary, Alberta, Canada
- University of Alberta - Mazankowski Alberta Heart Insitute, Edmonton, Alberta, Canada
- Hamilton General Hospital, Hamilton, Ontario, Canada
Other microbiome trials you might be interested in
ColchicineCoronary Atherosclerosis ManagementClonal Hematopoiesis of Indeterminate Potential
This study aims to investigate whether TET2-associated clonal hematopoiesis of indeterminate potential (TET2-CHIP) can s…
Shenyang, ChinaEst. completion May 1, 2028
ST Elevation Myocardial Infarction
Left ventricular remodeling is a common complication in patients with ST-elevation myocardial infarction (STEMI ) and ma…
Caen, FranceCompleted Oct 29, 2024
HypercholesterolemiaAtherosclerosis
This study will evaluate people with dyslipidemias - disorders that affect the fat content in the blood. Fats, or lipids…
Bethesda, United States